Intuitive Ventures

Murielle Thinard McLane is managing partner and president of Intuitive Ventures and leads the investment team. Terri Burke serves as senior partner, with Vivian Golfin, a physician, as senior associate and Vijay Rajasekhar, also a physician and MBA, as associate. Steve Gao is senior finance manager. The clinical weighting of the team matches a mandate running from neuromodulation and endobronchial devices to automated cell therapy manufacturing and AI decision support.

Gary Guthart, who leads Intuitive Surgical, serves as executive chairman of the venture arm, which keeps the parent's operating leadership directly attached to investment decisions. Four venture advisors round out the group: Bob DeSantis, Ross Jaffe, Beckie Robertson and Oern Stuge. The firm publishes names and titles only, without biographies, so prior roles and board assignments are not disclosed.

Intuitive Ventures is the corporate venture arm of Intuitive Surgical and invests from the parent's balance sheet rather than from limited partner commitments. No fund entity appears in SEC records, no numbered vehicle or vintage year is published, and there are no outside limited partners. The firm reports more than $250M in assets under management supporting early-stage companies, an average first investment of $5M to $10M or more, and a portfolio of fifteen or more companies.

Capital is deployed against a single thesis: minimally invasive care. That spans surgical robotics, digital health and imaging software, implantable devices, therapeutics and diagnostics, with Intuitive Surgical's thirty years of operating experience in robotic surgery offered as the differentiated resource. Because the vehicle is corporate rather than fund-structured, there is no fundraising cycle, no fixed investment period and no disclosed target size. Two holdings are marked as exited, the surgical AI company KelaHealth and the liver perfusion company OrganOx.